RPGLIFE2,780.00

RPG Life Sciences Limited

· Pharma & Health
₹ CrorePeersGUFICBIOGUJTHEMUNICHEMLABORCHPHARMASMSPHARMAFDCIOLCPINDSWFTLABMcap ₹4,597 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Non-current Assets
+ Property, Plant & Equipment194.1322.4191.7
+ Capital Work-in-Progress84.84.020.0
+ Investment Property1.0
+ Other Intangibles16.510.74.8
+ Intangibles under Development11.512.13.3
+ Non-current Investments1.01.00.4
+ Long-term Loans0.1
+ Other Non-current Financial Assets10.27.0
Non-current Financial Assets7.6
+ Deferred Tax Assets0.61.00.0
+ Other Non-current Assets1.50.5
Total Non-current Assets214.8192.6228.4
Current Assets
+ Inventories101.093.0123.8
+ Current Investments90.2125.983.9
+ Trade Receivables49.186.8116.7
+ Cash & Cash Equivalents19.728.7150.5
+ Other Bank Balances16.8110.941.1
+ Short-term Loans9.3
+ Other Current Financial Assets34.2
Current Financial Assets176.8358.1435.6
+ Other Current Assets20.314.2
Total Current Assets298.1465.3564.8
Total Assets512.9657.8793.2
Equity
+ Equity Share Capital13.213.213.2
+ Other Equity / Reserves361.6517.3592.2
Equity — Owners of Parent374.9530.5605.4
Total Equity374.9530.5605.4
Liabilities
+ Borrowings — Non-current13.3
+ Other Non-current Financial Liab3.02.93.4
Non-current Financial Liabilities16.8
+ Provisions — Non-current4.04.57.4
+ Deferred Tax Liabilities3.1
Non-current Liabilities7.17.527.2
+ Borrowings — Current6.7
+ Trade Payables71.079.497.2
+ Other Current Financial Liab39.817.620.4
Current Financial Liabilities97.0124.3
+ Provisions — Current12.216.129.1
+ Current Tax Liabilities1.2
+ Other Current Liabilities5.26.75.9
Current Liabilities131.0119.8160.5
Total Liabilities138.0127.3187.8
Total Equity & Liabilities512.9657.8793.2
Assets — additional as-filed lines
+ Current Tax Assets5.3
Trade Payables — MSME split
+ Dues to Micro & Small — Current5.1
+ Dues to Other Creditors — Current92.1
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.